“It’s really a bit of science fiction.”
In his latest interview with #SoftBankVisionFund, LUMICKS CEO Hugo de Wit shares how we're equipping researchers to uncover the molecular mechanisms behind cancer and other diseases.
www.linkedin.com/posts/softba...
In his latest interview with #SoftBankVisionFund, LUMICKS CEO Hugo de Wit shares how we're equipping researchers to uncover the molecular mechanisms behind cancer and other diseases.
www.linkedin.com/posts/softba...
LUMICKS’ latest biotech innovation seems like a call from the future, but it may change how researchers find cancer cures. | SoftBank Investment Advisers
LUMICKS’ latest biotech innovation seems like a call from the future, but it may change how researchers find cancer cures. The company’s C-TRAP tool is best described as two laser beams that can stret...
www.linkedin.com
July 7, 2025 at 9:10 AM
“It’s really a bit of science fiction.”
In his latest interview with #SoftBankVisionFund, LUMICKS CEO Hugo de Wit shares how we're equipping researchers to uncover the molecular mechanisms behind cancer and other diseases.
www.linkedin.com/posts/softba...
In his latest interview with #SoftBankVisionFund, LUMICKS CEO Hugo de Wit shares how we're equipping researchers to uncover the molecular mechanisms behind cancer and other diseases.
www.linkedin.com/posts/softba...